In the week of September 7, 2026, the landscape of revenue cycle management (RCM) continues to evolve as companies seek strategic growth through acquisitions and significant funding rounds. EnableComp's acquisition of ANI Healthcare Solutions highlights a strong focus on enhancing denial management capabilities within specialty RCM, while Thyme Care's substantial $125 million raise underscores the increasing investment in oncology solutions. This week reflects a clear trend of capital flowing toward innovative technologies and integrated services that aim to streamline operations and improve patient outcomes in healthcare.
Claim Denials & Denial Management (Google News)
EnableComp has acquired ANI Healthcare Solutions to enhance its denial management capabilities within its specialty revenue cycle management (RCM) platform. The financial terms of the deal were not disclosed. This acquisition signifies a strategic move to strengthen EnableComp's position in the RCM market, particularly in addressing denial management challenges for healthcare providers.
Source →Fierce Healthcare
Oncology company Thyme Care has secured over $125 million in a Series E funding round, supported by Morgan Health, Humana, and CVS Health Ventures. This financing aims to help Thyme Care expand its services beyond cancer care navigation. The key implication for the RCM market is the increasing interest from payers and providers in integrated care solutions, which could reshape how revenue cycle management is approached in oncology and beyond.
Source →Every deal, every week
Subscribe to the RevCycleAI newsletter. Free weekly RCM intelligence — deals, payer moves, and vendor deep dives.
Subscribe Free →